Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown LogicBio Therapeutics Inc. LOGC

LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform. Its product candidates include LB-001, LB-101, LB-201 and LB 301.


Top institutional share ownership of LogicBio Therapeutics Inc

Name Shares Shares % change Value Value % change
Orbimed Advisors Llc 8,466,783 0.0% $2,307 -22.2%
Vanguard Group Inc 499,932 59.4% $136 23.6%
Renaissance Technologies Llc 282,877 -32.6% $77 -47.6%
VEXMX - Vanguard Extended Market Index Fund Investor Shares 282,216 0.0% $77 -25.5%
HAMGX - Harbor Mid Cap Growth Fund Institutional Class 203,903 -14.2% $80 -23.1%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 186,229 -54.0% $51 -94.7%
BlackRock Inc. 170,945 -2.0% $47 -23.0%
Baker Bros. Advisors Lp 139,105 -69.2% $38 -76.0%
Geode Capital Management, Llc 138,465 0.0% $37 -26.0%
FBDIX - Franklin Biotechnology Discovery Fund Class A 120,913 -60.6% $47 -65.2%

Top institutional buyers of LogicBio Therapeutics Inc

Name Shares % change Value % change Shares Value
Vanguard Group Inc 59.4% 23.6% 499,932 $136
Prudential Financial Inc 54.1% 17.4% 98,600 $27
ITOT - iShares Core S&P Total U.S. Stock Market ETF 0.7% -28.6% 19,560 $5

Top institutional sellers of LogicBio Therapeutics Inc

Name Shares % change Value % change Shares Value
Baker Bros. Advisors Lp -69.2% -76.0% 139,105 $38
FBDIX - Franklin Biotechnology Discovery Fund Class A -60.6% -65.2% 120,913 $47
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares -54.0% -94.7% 186,229 $51
Renaissance Technologies Llc -32.6% -47.6% 282,877 $77
BRSIX - Ultra-Small Company Market Fund Class N -22.9% -44.0% 53,900 $15
Bridgeway Capital Management Inc -22.9% -40.0% 53,900 $15
HAMGX - Harbor Mid Cap Growth Fund Institutional Class -14.2% -23.1% 203,903 $80
BlackRock Inc. -2.0% -23.0% 170,945 $47
FSMAX - Fidelity Extended Market Index Fund -0.8% -27.5% 81,903 $29

Information provided by Fintel.io